CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 630 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03434457
NCT03434457N/ACompleted

Maternal Adversity, Vulnerability and Neurodevelopment

Douglas Mental Health University Institute·observational·Posted Feb 15, 2018·Updated May 27, 2020

In Brief

An observational study for Mental Health Issue (E.G., Depression, Psychosis, Personality Disorder, Substance Abuse) and 2 related conditions. Completed, enrolled 630 participants across 1 site.

Detailed Summary

Maternal Adversity Vulnerability and Neurodevelopment (MAVAN) project is a prospective community-based, pregnancy and birth cohort of Canadian mother-child dyads. The main objective of MAVAN project is to examine the pre- and postnatal influences, and their interaction, in determining individual differences in children development. The MAVAN project is designed to examine the consequences of fetal adversity as a function of the quality of the postnatal environment, focusing on mother-infant interactions.

Study Details

Timeline

N/ACompletedFinished
200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedFeb 15, 2018
Enrollment StartOct 1, 2003
Primary CompletionDec 1, 2017
TodayJul 2, 2026
Enrollment to primary: 14.2 yearsPosted 8.4 years ago